Impact of response to hypomethylating agent-based therapy on survival outcomes in the context of baseline clinical-molecular risk and transplant status in patients with myelodysplastic syndromes/neoplasms (MDS): An analysis from the international consortium for MDS (icMDS) validate database Meeting Abstract

  

Authors:	Rolles, B.; Bewersdorf, J. P.; Kewan, T.; Blaha, O.; Stempel, J. M.; Lanino, L.; Al Ali, N. H.; DeZern, A. E.; Sekeres, M. A.; Uy, G. L.; Carraway, H. E.; Desai, P.; Griffiths, E. A.; Stein, E. M.; Brunner, A. M.; McMahon, C. M.; Shallis, R. M.; Zeidner, J. F.; Savona, M. R.; Frumm, S. M.; Barua, S.; Chandhok, N. S.; Logothetis, C.; Bidikian, A.; Getz, T. M.; Roboz, G. J.; Wang, E. S.; Harris, A. C.; Amaya, M. L.; Hawkins, H.; Ball, S.; Grenet, J.; Xie, Z.; Madanat, Y. F.; Abaza, Y.; Badar, T.; Haferlach, T.; Maciejewski, J.; Sallman, D.; Enjeti, A. K.; Al-Rabi, K.; Halahleh, K.; Hiwase, D.; Diez-Campelo, M.; Valcarcel, D.; Haferlach, C.; Pleyer, L.; Kotsianidis, L.; Pappa, V.; Santini, V.; Consagra, A.; Al-Kali, A.; Ogawa, S.; Nannya, Y.; Porta, M. G. D.; Komrokji, R. S.; Zeidan, A. M.; Stahl, M.
Abstract Title:	Impact of response to hypomethylating agent-based therapy on survival outcomes in the context of baseline clinical-molecular risk and transplant status in patients with myelodysplastic syndromes/neoplasms (MDS): An analysis from the international consortium for MDS (icMDS) validate database
Meeting Title:	66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	144
Issue:	Suppl. 1
Meeting Dates:	2024 Dec 7-10
Meeting Location:	San Diego, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2024-11-05
Start Page:	664
End Page:	668
Language:	English
ACCESSION:	WOS:001415676400013
DOI:	10.1182/blood-2024-208034
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/226877